| miR-23b-3p is an oncogenic miRNA and inhibits PTEN tumor suppressor gene in renal cell carcinoma. | kidney, |
| MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. | bladder, |
| miR-23b and miR-27b function as tumor suppressors, targeting several oncogenic genes in clear cell renal cell carcinoma cells | kidney, |
| downregulation of the miR-23b/27b/24-1 cluster was a frequent event in prostate cancer, and these clustered miRNAs functioned as tumor suppressors | prostate, |
| miR-23b as a potential tumor suppressor and its regulation by DNA methylation in cervical cancer | cervical, |
| Results showed that miR-23b and miR-27b were frequently reduced in oral squamous cell carcinoma clinical specimens and appeared to act as tumor suppressors through targeting of the MET oncogene in this disease. | oral |
| miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. | kidney, |
| Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. | kidney, |
| miR-23b-3p is an oncogenic miRNA and inhibits PTEN tumor suppressor gene in renal cell carcinoma. | kidney, |
| Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-alpha in breast cancer. | breast, |
| results demonstrate that miR-23b and miR-27b are primarily oncogenic in MCF7 breast cancer cells | breast, |
| miR-23b, by targeting proline oxidase, could function as an oncogene. | None |